Log In
Print
BCIQ
Print
Print this Print this
 

SCIB1

  Manage Alerts
Collapse Summary General Information
Company Scancell Holdings plc
DescriptionCancer vaccine comprising the melanoma antigen tyrosinase-related protein 2 (TRP-2; TYRP2; DCT) and 2 helper T cell epitopes
Molecular Target Tyrosinase-related protein 2 (TRP-2) (TYRP2) (DCT)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation

U.S. - Orphan Drug (Treat melanoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today